Sbk Financial, Inc. Bristol Myers Squibb CO Transaction History
Sbk Financial, Inc.
- $63 Million
- Q4 2022
A detailed history of Sbk Financial, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sbk Financial, Inc. holds 7,000 shares of BMY stock, worth $441,770. This represents 0.8% of its overall portfolio holdings.
Number of Shares
7,000
Previous 7,000
-0.0%
Holding current value
$441,770
Previous $498,000
1.0%
% of portfolio
0.8%
Previous 0.76%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,761Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$12 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$10 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$6.06 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$6 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.81 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $134B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...